Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
about
Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast CancerBone morphogenetic proteins, breast cancer, and bone metastases: striking the right balance.Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.PIK3CA mutation, reduced AKT serine 473 phosphorylation, and increased ERα serine 167 phosphorylation are positive prognostic indicators in postmenopausal estrogen receptor-positive early breast cancer.Economic Evaluation of Letrozole for Early Breast Cancer in a Health Resource-Limited Setting
P2860
Q37059543-E36F6B00-CE93-4D32-90B8-19A8FADD5C43Q38748794-BE5456F3-35DE-44FD-8C48-B05A1941FF7CQ38820550-4764CC75-7A95-40D1-8AC1-6639A2CB3A69Q39451397-B7639971-D64A-4FDE-BA76-7DEA07A31B64Q40581595-8C011AD9-78CE-4AD9-A744-9E05B90C536DQ47204606-94C67BE4-598E-41B8-AEAD-57C08EC9C06FQ55001013-F8C31A46-F1F5-49B8-9D49-309CBC25079EQ58803015-F4B9C8FD-E220-4A86-8B1F-44459FF9BCB1
P2860
Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@en
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@nl
type
label
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@en
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@nl
prefLabel
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@en
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@nl
P2093
P2860
P1433
P1476
Clinicopathological factors pr ...... , HER2-negative breast cancer.
@en
P2093
Akiko Ogiya
Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Hiroko Yamashita
Hiroyuki Yasojima
Kieko Yamazaki
Masato Takahashi
Mitsuchika Hosoda
Naoko Ishida
Nobumoto Tomioka
Norikazu Masuda
P2860
P2888
P304
P356
10.1007/S12282-015-0649-0
P577
2015-10-14T00:00:00Z
P5875
P6179
1022349191